• Dr. Lisa Diller

    Working with Adult Survivors of Childhood Cancer

    Today, 80 percent of childhood cancer patients survive into adulthood, but many experience late effects of their treatment. The Boston Globe spoke with Lisa Diller, MD, about issues facing survivors of childhood cancer and how new treatments are helping to reduce long-term effects.
    sickle cell blood cell

    Hope Grows for Sickle Cell Disease Patients

    Advances in research and treatment are changing sickle cell disease from an inherited condition that often condemned children to painful and short lives into a condition that can be managed with less pain and a longer life expectancy, the Washington Post reports.
    Alisha AT/RT

    Young Girl’s Cancer Fight Intersects with Researcher’s Quest

    A young Irish couple brought their 3-year-old daughter, Alisha, to Boston for treatment of her rare brain tumor at Dana-Farber/Boston Children’s. Meanwhile, research into this cancer — atypical teratoid rhabdoid tumors (ATRT) — by a Dana-Farber/Boston Children’s scientist could hold a key to understanding and treating many other, more common malignancies, including some forms of lung, ovarian, brain, and colon cancers.

    Lives Less Ordinary: Pediatric Palliative Care

    Now that chronically ill children are living longer than ever, how should we care for them? The Pediatric Advanced Care Team at Dana-Farber/Boston Children's, which provides palliative care, may serve as a model. Pediatric palliative care helps children like 11-year-old Gwen Lorimer, who has spent much of her life in and out of hospitals, The New Yorker magazine reports.
    Boy gene therapy treatment

    Gene Therapy Keeps “Bubble Boy” Disease at Bay

    Researchers report promising results of a gene therapy trial aimed at curing the genetic defect that causes some children to be born without immune defenses, a rare condition also known as “bubble boy” disease, NPR reports. Scientists now report that 8 out of 9 young children given gene therapy for a type of severe combined immunodeficiency disease, called SCID-X1, are alive and living amid the everyday microbial threats that would otherwise have killed them.
  • Rated One of Best Hospitals

    US News

    Rated one of best hospitals in the U.S. for childhood cancer care

  • Innovative Treatments

    Gene Therapy Callout2 

    Through clinical trials and research, Dana-Farber/Boston Children's is at the forefront of innovative treatments, including gene therapy.

  • Five Things Parents of Children with Cancer Should Know

    parent and doctor with child with cancer

    If your child has cancer, stay positive. With advances in research and treatment, the five-year survival rate is 84 percent for all childhood cancers combined, up from 61 percent in the mid-1970s.